EYPT — EYEPOINT PHARMACEUTICALS INC

Ownership history in Caption Management, LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in EYEPOINT PHARMACEUTICALS INC (EYPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.1% (2024 Q2)
Avg. % of fund
0.03%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 120,000 +103,000 +605.9% 0.01% $1.7M $14.24
2025 Q3 REDUCED 17,000 -102,566 -85.8% 0.00% $242K $14.24
2025 Q2 REDUCED 119,566 -100,734 -45.7% 0.01% $1.1M $9.41
2025 Q2 ADDED 220,300 +94,410 +75.0% 0.02% $2.1M $9.41
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    EYPT price (monthly, adj. close)

Other funds also holding EYPT

As of 2025 Q4 — sorted by position size

Cormorant Asset Management, LP 3Y 7Y 6.98% Essex Woodlands Management, Inc. 3Y 7Y 6.23% 5AM Venture Management, LLC 3Y 6.03% Rosalind Advisors, Inc. 4.43% Patient Square Capital LP 3Y 3.05% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.93% TCG Crossover Management, LLC 3Y 2.16% Artia Global Partners LP 3Y 1.99% Parkman Healthcare Partners LLC 3Y 1.89% Paradigm Biocapital Advisors LP 3Y 1.72%
← Back to Caption Management, LLC Holdings